المؤلفون: Tsuchida S; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine., Matsuzaki T; Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University., Yamato M; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine., Okuda K; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine., Fu HY; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine., Araki R; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine., Sanada S; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine., Asanuma H; Department of Internal Medicine, Meiji University of Integrative Medicine., Asano Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine., Asakura M; Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine., Hao H; Department of Pathology, Nihon University School of Medicine., Takashima S; Department of Medical Biochemistry, Osaka University Graduate School of Medicine., Kitakaze M; Clinical Research and Development, National Cerebral and Cardiovascular Center Research Institute., Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine., Mekada E; Department of Cell Biology, Research Institute for Microbial Diseases, Osaka University., Minamino T; Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University.

المصدر: International heart journal [Int Heart J] 2018 Nov 28; Vol. 59 (6), pp. 1425-1431. Date of Electronic Publication: 2018 Nov 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Heart Journal Association Country of Publication: Japan NLM ID: 101244240 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-3299 (Electronic) Linking ISSN: 13492365 NLM ISO Abbreviation: Int Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies/*therapeutic use , Atherosclerosis/*therapy , Avidin/*immunology , Genetic Therapy/*methods , Heparin-binding EGF-like Growth Factor/*immunology , RNA, Small Interfering/*therapeutic use, Animals ; Atherosclerosis/metabolism ; Humans ; Mice ; Mice, Knockout ; Treatment Outcome

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.